J. Kizu et al., Preparation and clinical application of 2% diflunisal oral ointment for painful lesions of the oral mucosa, YAKUGAKU ZA, 121(11), 2001, pp. 829-835
Citations number
18
Categorie Soggetti
Pharmacology & Toxicology
Journal title
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
We previously reported the development and clinical efficacy of a 2% aspiri
n oral ointment and 2% ethenzamide oral ointment as hospital preparations f
or painful lesions of the oral mucosa. This study investigated methods of p
reparing a more stable oral ointment with a more effective analgesic action
, using diflunisal, another salicylic acid derivative, with an analgesic ef
fect stronger than that of aspirin. A two-percent diflunisal oral ointment
was prepared similarly to the aspirin ointment using plastibase and CMC-Na
as the ointment base. From the results of spreadability measurement, a CMC-
Na content of 20% was considered appropriate. The stability of diflunisal i
n 2% diflunisal oral ointment stored at 5 degreesC, 20 degreesC and 30 degr
eesC, was determined using HPLC, and a high stability of diflunisal at room
temperature for more than 100 days was confirmed. We also investigated its
antinociceptive effect using the Randall-Selitto paw pressure test in rats
, which showed that 2% diflunisal oral ointment was as effective as 2% aspi
rin oral ointment. On clinical application of 2 % diflunisal oral ointment
to 8 patients with painful oral mucous diseases, it was found to be signifi
cantly (p=0.014) more effective than 2% aspirin oral ointment. The results
of this study demonstrated that 2% diflunisal oral ointment is a clinically
useful analgesic for painful oral lesions.